Who
Peter H. Griffith
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Mattel; EVP & CFO, Amgen.
In numbers
- Trades disclosed
- 48
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 5 May 2020
- Last trade
- 20 Oct 2026
- Last filed
- 21 Oct 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 Oct 2026filed 21 Oct 2026 | MAT Matteloption or derivative · Leisure Products & Vehicles | SEC FORM 4 Code A | —58,858 at $0.00 | filing |
| 20 Oct 2026filed 21 Oct 2026 | MAT Matteloption or derivative · Leisure Products & Vehicles | SEC FORM 4 Code A | —147,145 at $0.00 | filing |
| 7 May 2026filed 11 May 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code F | $184K556 at $331.11 | filing |
| 7 May 2026filed 11 May 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code F | $184K556 at $331.11 | filing |
| 6 May 2026filed 7 May 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code F | $165K502 at $329.59 | filing |
| 6 May 2026filed 7 May 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code F | $165K502 at $329.59 | filing |
| 5 May 2026filed 7 May 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code A | —3,640 at $0.00 | filing |
| 5 May 2026filed 7 May 2026 | AMGN Amgenoption or derivative · Biotechnology | SEC FORM 4 Code A | $7.8M23,752 at $329.59 | filing |
| 5 May 2026filed 7 May 2026 | AMGN Amgenoption or derivative · Biotechnology | SEC FORM 4 Code A | $7.8M23,752 at $329.59 | filing |
| 5 May 2026filed 7 May 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code A | —3,640 at $0.00 | filing |
| 2 May 2026filed 5 May 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code F | $246K746 at $329.82 | filing |
| 2 May 2026filed 5 May 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code F | $227K687 at $329.82 | filing |
| 2 May 2026filed 5 May 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code F | $246K746 at $329.82 | filing |
| 2 May 2026filed 5 May 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code F | $227K687 at $329.82 | filing |
| 16 Mar 2026filed 18 Mar 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code F | $2.1M5,748 at $366.21 | filing |
| 16 Mar 2026filed 18 Mar 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code F | $2.1M5,748 at $366.21 | filing |
| 3 Mar 2026filed 5 Mar 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code A | —12,063 at $0.00 | filing |
| 3 Mar 2026filed 5 Mar 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code A | —12,063 at $0.00 | filing |
| 6 May 2025filed 8 May 2025 | AMGN Amgenoption or derivative · Biotechnology | SEC FORM 4 Code A | $6.9M25,334 at $270.44 | filing |
| 6 May 2025filed 8 May 2025 | AMGN AmgenBiotechnology | SEC FORM 4 Code A | —3,919 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.